Skip to main content
SpringerLink
Log in

Point-of-Care Testing in Oral Anticoagulant Monitoring

Implications for Patient Management

  • Review Article
  • Published:
Disease Management and Health Outcomes

Abstract

Capillary whole blood point-of-care instruments for prothrombin time testing have been available for the last 10 years for use both in an office or hospital setting as well as at home by patients for self-monitoring of oral anticoagulant therapy. There are currently 4 types of instruments available, all of which initiate coagulation with thromboplastin, but the end-point determination of coagulation differs in the various instruments. The accuracy and precision of these instruments have been validated in a number of studies and their suitability for monitoring oral anticoagulation therapy has been established. A number of small pilot trials have assessed their value for patient self-testing at home and have produced preliminary evidence that such monitoring may produce better results than achieved with monitoring performed in the usual fashion.

A number of studies have also shown that suitably educated patients can also manage their own dosage adjustments based on their own testing at home. Furthermore, preliminary studies also suggest that such monitoring is a cost-effective means of managing oral anticoagulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1998; 114: 445S–469S

    Article  PubMed  CAS  Google Scholar 

  2. Albers GW, Yim JM, Belew KM, et al. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med 1996; 156: 2311–6

    Article  PubMed  CAS  Google Scholar 

  3. Munschauer FE, Priore RL, Hens M, et al. Thromboembolism prophylaxis in chronic atrial fibrillation: practice patterns in community and tertiary care hospitals. Stroke 1997; 28: 72–6

    Article  PubMed  CAS  Google Scholar 

  4. Kutner M, Nixon G, Silverstone F. Physicians’ attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 1991; 151: 1950–3

    Article  PubMed  CAS  Google Scholar 

  5. McCrory DC, Matchar DB, Samsa G, et al. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995; 155: 277–81

    Article  PubMed  CAS  Google Scholar 

  6. Hylek EM, Skates SJ, Sheehan MA, et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996; 335: 540–6

    Article  PubMed  CAS  Google Scholar 

  7. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994; 120: 897–902

    PubMed  CAS  Google Scholar 

  8. College of American Pathologists Coagulation Survey Set 1997 CG2-C. Northfield (IL): College of American Pathologists, 1997

  9. Leaning KE, Ansell JE. Advances in the monitoring of oral anticoagulation: point-of-care testing, patient self-monitoring, and patient self-management. J Thrombo Thrombolysis 1996; 3: 377–83

    Google Scholar 

  10. Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 1996; 132: 1095–100

    Article  PubMed  CAS  Google Scholar 

  11. Garabedian-Ruffalo SM, Gray DR, Sax MJ, et al. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985; 42: 304–8

    PubMed  CAS  Google Scholar 

  12. Cortelazzo S, Finazzi G, Verio P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993; 69: 316–20

    PubMed  CAS  Google Scholar 

  13. Wilt VM, Gums JG, Ahmed OI, et al. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy 1995; 15: 732–9

    PubMed  CAS  Google Scholar 

  14. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic and usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998; 158: 1641–7

    Article  PubMed  CAS  Google Scholar 

  15. Leaning KE, Ansell JE. Capillary whole blood prothrombin time monitoring: instrumentation and methodologies. In: Ansell J, Oertel L, Wittkowsky A, editors. Managing oral anticoagulation therapy. Gaithersburg (MD): Aspen Publishers, 1997; 3B5: 1–5

    Google Scholar 

  16. White RH, Becker DM, Gunther-Maher MG. Outpatient use of a portable International Normalized Ratio/Prothrombin time monitor. South Med J 1994; 87: 206–10

    Article  PubMed  CAS  Google Scholar 

  17. Zweig SE, Meyer BG, Sharma S, et al. Membrane-based, dryreagent prothrombin time tests. Biomed Intrum Technol 1996; 30: 245–56

    CAS  Google Scholar 

  18. Lucas FV, Duncan A, Jay R, et al. A novel whole blood capillary technique for measuring prothrombin time. Am J Clin Pathol 1987; 88: 442–6

    PubMed  CAS  Google Scholar 

  19. Weibert RT, Adler DS. Evaluation of a capillary whole blood prothrombin time measurement system. Clin Pharm 1989; 8: 864–7

    PubMed  CAS  Google Scholar 

  20. Yano Y, Kambayashi J, Murata K, et al. Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor. Thromb Res 1992; 66: 583–90

    Article  PubMed  CAS  Google Scholar 

  21. Foulis PR, Wallach PM, Adelman HM, et al. Performance of the Coumatrak system in a large anticoagulation clinic. Am J Clin Pathol 1995; 103: 98–102

    PubMed  CAS  Google Scholar 

  22. Jennings I, Luddington RJ, Baglin T. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J Clin Pathol 1991; 44: 950–3

    Article  PubMed  CAS  Google Scholar 

  23. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 1992; 152: 589–92

    Article  PubMed  CAS  Google Scholar 

  24. Bussey HI, Chiquette E, Bianco TM, et al. A statistical and clinical evaluation of fingerstick and routine laboratory prothrombin time measurements. Pharmacotherapy 1997; 17: 861–6

    PubMed  CAS  Google Scholar 

  25. Tripodi A, Arbino AA, Chantarangkul V, et al. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulation treatment by the International Normalized Ratio? Thromb Haemost 1993; 70: 921–4

    PubMed  CAS  Google Scholar 

  26. Oberhardt BJ, Dermott SC, Taylor M, et al. Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. Clin Chem 1991; 37: 520–6

    PubMed  CAS  Google Scholar 

  27. Kapiotis S, Quehendberger P, Speiser W Evaluation of the new method CoaguChek™ for the determination of prothrombin time from capillary blood: comparison with thrombotest on KC-1. Thromb Res 1995; 77: 563–7

    Article  PubMed  CAS  Google Scholar 

  28. Hasenkam JM, Knudson L, Kimose HH, et al. Practicability of patient-self-testing of oral anticoagulant therapy by the INR using a portable whole blood monitor. Thromb Res 1997; 85: 77–82

    Article  PubMed  CAS  Google Scholar 

  29. Van den Besselaar AMHP, Breddin K, Lutze BG, et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagul Fibrinolysis 1995; 6: 726–32

    Article  PubMed  Google Scholar 

  30. Fabbrini N, Messmore H, Balbale S, et al. Pilot study to determine use of a TAS analyzer in an anticoagulation clinic setting. Blood 1995; 8 Suppl. 1: 869a

    Google Scholar 

  31. Tripodi A, Chantarangkul V, Clerici M, et al. Determination of the international sensitivity index of a new near-patient testing device to monitor oral anticoagulant therapy. Thromb Haemost 1997; 78: 855–8

    PubMed  CAS  Google Scholar 

  32. Cachia PG, McGregor E, Adlakha S, et al. Accuracy and precision of the TAS analyser for near-patient INR testing by non-pathology staff in the community. J Clin Pathol 1998; 51: 68–72

    Article  PubMed  CAS  Google Scholar 

  33. Kaatz AA, White RH, Hill J, et al. Accuracy of laboratory and portable monitor International Normalized Ratio determinations. Arch Intern Med 1995; 155: 1861–7

    Article  PubMed  CAS  Google Scholar 

  34. Ansell J, Becker D, Andrew M, et al. Accurate and precise prothrombin time measurement in a multicenter anticoagulation trial employing patient self testing. Blood 1995: 86 Suppl. 1: 864a

    Google Scholar 

  35. Andrew M, Marzinotto V, Adams M, et al. Monitoring of oral anticoagulant therapy in pediatric patients using a new microsample PT device. Blood 1995; 86 Suppl. 1: 863a

    Google Scholar 

  36. Ansell JE, Zweig S, Meyer B, et al. Performance of the Avocet Prothrombin Time (PT)/INR system. Blood 1998; 92 Suppl. 1: 112b

    Google Scholar 

  37. Belsey RE, Fischer PM, Baer DM. An evaluation of a whole blood prothrombin analyzer designed for use by individuals without formal laboratory training. J Fam Pract 1991; 33: 266–71

    PubMed  CAS  Google Scholar 

  38. White RH, McCurdy A, Marensdorff H, et al. Home prothrombin time monitoring after the initiation of warfarin therapy; a randomized, prospective study. Ann Intern Med 1989; 111: 730–7

    PubMed  CAS  Google Scholar 

  39. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993; 153: 1441–7

    Article  PubMed  CAS  Google Scholar 

  40. Andrew M, Ansell J, Becker D, et al. Multicenter trial of accurate home self-testing in oral anticoagulant patients with a novel whole blood system. Blood 1996; 88 Suppl. 1: 179a

    Google Scholar 

  41. Beyth RJ, Landefeld CS. Prevention of major bleeding in older patients treated with warfarin: results of a randomized trial [abstract]. J Gen Intern Med 1997; 12: 66

    Google Scholar 

  42. Ansell J, Holden A, Knapic N. Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times. Arch Intern Med 1989; 149: 2509–11

    Article  PubMed  CAS  Google Scholar 

  43. Ansell JE, Patel N, Ostrovsky D, et al. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995; 155: 2185–9

    Article  PubMed  CAS  Google Scholar 

  44. Bernardo A. Experience with patient self-management of oral anticoagulation. J Thromb Thrombolysis 1996; 2: 321–5

    Article  Google Scholar 

  45. Horstkotte D, Piper C, Wiemer M, et al. Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulant therapy. Eur Heart J 1996; 17 Suppl.: 230

    Google Scholar 

  46. Hasenkam JM, Kimose HH, Knudsen L, et al. Self-management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg 1997; 11: 935–42

    Article  PubMed  CAS  Google Scholar 

  47. Sawicki PT, Working Group for the Study of Patient Self-Management of Oral Anticoagulation. A structured teaching and self-management program for patients receiving oral anticoagulation. A randomized controlled trial. JAMA 1999; 281: 145–50

    Article  PubMed  CAS  Google Scholar 

  48. Ansell J, Hamke K, Holden A, et al. Cost effectiveness of monitoring warfarin therapy using standard versus capillary prothrombin times. J Clin Pathol 1989; 91: 587–9

    CAS  Google Scholar 

  49. Eckman MH, Levine JH, Pauker SG. Making decisions about antithrombotic therapy in heart disease. Chest 1995; 108 Suppl.: 457S–470S

    Article  PubMed  CAS  Google Scholar 

  50. Matchar DB, Samsa GP, Cohen SJ. Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation. J Gen Intern Med 1996; 11: 768–70

    Article  PubMed  CAS  Google Scholar 

  51. Elston Lafata J. Monitoring alternatives for patients on anticoagulation therapy: a cost-effectiveness analysis. XXth Congress of the European Society of Cardiology; 1998 Aug 22; Vienna, Austria

  52. Ansell JE, Buttaro ML, Voltis-Thomas, O, et al. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Ann Pharmacother 1997; 31: 604–15

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy Practice, School of Pharmacy, Northeastern University, Boston, Massachusetts, USA

    Jennifer Sickels

  2. Center for Clinical Effectiveness, Henry Ford Health System, Detroit, Michigan, USA

    Jennifer Elston Lafata

  3. Department of Medicine, Boston Medical Center, 88 E. Newton Street, Boston, Massachusetts, 02118, USA

    Jack E. Ansell (Professor of Medicine and Vice Chair, Director of the Anticoagulation Clinic)

Authors
  1. Jennifer Sickels
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Elston Lafata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jack E. Ansell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jack E. Ansell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sickels, J., Lafata, J.E. & Ansell, J.E. Point-of-Care Testing in Oral Anticoagulant Monitoring. Dis-Manage-Health-Outcomes 6, 291–301 (1999). https://doi.org/10.2165/00115677-199906050-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-199906050-00006

Keywords

Search

Navigation